Maiju Merisalo-Soikkeli

Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor

Siri Tähtinen, Susanna Grönberg-Vähä-Koskela, Dave Lumén et al. · Cancer Immunology Research · 2015 · 65 citations · Full text

Immunology, Immunoediting, Pathology +18

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

Ilkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli et al. · OncoImmunology · 2015 · 58 citations · Full text

Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors

Siri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli et al. · PLoS ONE · 2015 · 47 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +26

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Simona Bramante, Anniina Koski, Anja Kipar et al. · International Journal of Cancer · 2013 · 44 citations

Tumor Biology, Cancer Immunosurveillance, Malignant Disease +13